Phio Pharmaceuticals
PHIO
#10948
Rank
C$13.84 M
Marketcap
C$1.16
Share price
-0.07%
Change (1 day)
-46.71%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -C$18.03 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$12.4 Million a decrease over its 2024 earnings that were of -C$10.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$18.03 Million45.42%
2025 -C$12.4 Million21.65%
2024 -C$10.19 Million-33.96%
2023 -C$15.43 Million-5.7%
2022 -C$16.36 Million-13.6%
2021 -C$18.94 Million51.09%
2020 -C$12.53 Million-1.28%
2019 -C$12.7 Million21.03%
2018 -C$10.49 Million-53.1%
2017 -C$22.36 Million74.49%
2016 -C$12.82 Million-12.02%
2015 -C$14.57 Million16.17%
2014 -C$12.54 Million-57.95%
2013 -C$29.82 Million62.45%
2012 -C$18.36 Million0.87%
2011 -C$18.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.23 Billion 1,133.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.87 Million 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA